immune disorders primary immune deficiencies
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
2 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients: a diagnosis of a clinically relevant primary immunodeficiency or a strong suspicion of a diagnosis of primary immunodeficiency Healthy controls: healthy family or household members and/or friends of patients Both groups: informed consent
Exclusion criteria
Exclusion criteria: No consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ad 1. prospective follow up study. - Survival data - Occurrence of complications, predominantly in the pulmonary, gastro intestinal, hematological tracts, as well as the occurrence of malignancies - These data will be related to clinical and laboratory phenotype Ad 2. improved diagnostics. - Genetic and associated functional defects causative of primary immunodeficiencies. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ad 1. prospective follow up study. - Quality of life parameters - Enhanced understanding of the healthy (mucosal) immune system Ad 2. improved diagnostics. - No secondary study outcome parameters. | — |
Countries
Netherlands
Outcome results
None listed